Atlas Trials

Randomized, Crossover Bioequivalence Study of PL-ASA Versus Immediate Release Aspirin in Healthy Volunteers.

Clinical trial NCT05055752 · COMPLETED

Trial details

NCT number
NCT05055752
Sponsor
PLx Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2020-05-07
Primary completion
2020-06-29
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.